FDA promises quick review of Pfizer booster for all adults, possibly Friday

FDA promises quick review of Pfizer booster for all adults, CDC meets Friday The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's request to authorize booster doses of COVID-19 vaccine in all adults "as expeditiously as possible," with the New York Times reporting that the regulatory nod could come as soon as Thursday. Reuters Reuters

Nov 16 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it would review Pfizer Inc's (PFE.N) request to authorize booster doses of COVID-19 vaccine in all adults "as expeditiously as possible," with the New York Times reporting that the regulatory nod could come as soon as Thursday.

The agency said it does not plan to hold a meeting of the outside experts on Pfizer's request, concluding the request does not raise questions that would benefit from additional discussion by the members of the committee. ...